Exact Mass: 453.2045

Exact Mass Matches: 453.2045

Found 95 metabolites which its exact mass value is equals to given mass value 453.2045, within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error 0.001 dalton.

3-Oxogentamicin A2

3-Oxogentamicin A2

C17H31N3O11 (453.1958)


   

2-(3-(2-Aminoethyl)-1h-indol-5-yloxy)acetyl-l-tyrosyl-glycinamide

2-[(2-{[3-(2-aminoethyl)-1H-indol-5-yl]oxy}-1-hydroxyethylidene)amino]-N-[(C-hydroxycarbonimidoyl)methyl]-3-(4-hydroxyphenyl)propanimidate

C23H27N5O5 (453.2012)


   

2-[[N-Methyl-N-[5-guanidino-2-[(2-amino-3-methylbutyryl)amino]pentanoyl]hydrazino]phosphonyl]-2-hydroxyacetic acid methyl ester

2-[[N-Methyl-N-[5-guanidino-2-[(2-amino-3-methylbutyryl)amino]pentanoyl]hydrazino]phosphonyl]-2-hydroxyacetic acid methyl ester

C15H32N7O7P (453.2101)


   
   

Cys Phe Gly Lys

(2S)-6-amino-2-{2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]acetamido}hexanoic acid

C20H31N5O5S (453.2046)


   

Cys Phe Lys Gly

2-[(2S)-6-amino-2-[(2S)-2-[(2R)-2-amino-3-sulfanylpropanamido]-3-phenylpropanamido]hexanamido]acetic acid

C20H31N5O5S (453.2046)


   

Cys Gly Phe Lys

(2S)-6-amino-2-[(2S)-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}-3-phenylpropanamido]hexanoic acid

C20H31N5O5S (453.2046)


   

Cys Gly Lys Phe

(2S)-2-[(2S)-6-amino-2-{2-[(2R)-2-amino-3-sulfanylpropanamido]acetamido}hexanamido]-3-phenylpropanoic acid

C20H31N5O5S (453.2046)


   

Cys Lys Phe Gly

2-[(2S)-2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]-3-phenylpropanamido]acetic acid

C20H31N5O5S (453.2046)


   

Cys Lys Gly Phe

(2S)-2-{2-[(2S)-6-amino-2-[(2R)-2-amino-3-sulfanylpropanamido]hexanamido]acetamido}-3-phenylpropanoic acid

C20H31N5O5S (453.2046)


   

Phe Cys Gly Lys

(2S)-6-amino-2-{2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]acetamido}hexanoic acid

C20H31N5O5S (453.2046)


   

Phe Cys Lys Gly

2-[(2S)-6-amino-2-[(2R)-2-[(2S)-2-amino-3-phenylpropanamido]-3-sulfanylpropanamido]hexanamido]acetic acid

C20H31N5O5S (453.2046)


   

Phe Gly Cys Lys

(2S)-6-amino-2-[(2R)-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}-3-sulfanylpropanamido]hexanoic acid

C20H31N5O5S (453.2046)


   

Phe Gly Lys Cys

(2R)-2-[(2S)-6-amino-2-{2-[(2S)-2-amino-3-phenylpropanamido]acetamido}hexanamido]-3-sulfanylpropanoic acid

C20H31N5O5S (453.2046)


   

Phe Lys Cys Gly

2-[(2R)-2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]-3-sulfanylpropanamido]acetic acid

C20H31N5O5S (453.2046)


   

Phe Lys Gly Cys

(2R)-2-{2-[(2S)-6-amino-2-[(2S)-2-amino-3-phenylpropanamido]hexanamido]acetamido}-3-sulfanylpropanoic acid

C20H31N5O5S (453.2046)


   

Gly Cys Phe Lys

(2S)-6-amino-2-[(2S)-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]-3-phenylpropanamido]hexanoic acid

C20H31N5O5S (453.2046)


   

Gly Cys Lys Phe

(2S)-2-[(2S)-6-amino-2-[(2R)-2-(2-aminoacetamido)-3-sulfanylpropanamido]hexanamido]-3-phenylpropanoic acid

C20H31N5O5S (453.2046)


   

Gly Phe Cys Lys

(2S)-6-amino-2-[(2R)-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]-3-sulfanylpropanamido]hexanoic acid

C20H31N5O5S (453.2046)


   

Gly Phe Lys Cys

(2R)-2-[(2S)-6-amino-2-[(2S)-2-(2-aminoacetamido)-3-phenylpropanamido]hexanamido]-3-sulfanylpropanoic acid

C20H31N5O5S (453.2046)


   

Gly Lys Cys Phe

(2S)-2-[(2R)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H31N5O5S (453.2046)


   

Gly Lys Phe Cys

(2R)-2-[(2S)-2-[(2S)-6-amino-2-(2-aminoacetamido)hexanamido]-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H31N5O5S (453.2046)


   

His Asn Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C18H27N7O7 (453.1972)


   

His Asn Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O7 (453.1972)


   

His Pro Asn Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-hydroxypropanoic acid

C18H27N7O7 (453.1972)


   

His Pro Ser Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-carbamoylpropanoic acid

C18H27N7O7 (453.1972)


   

His Ser Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O7 (453.1972)


   

His Ser Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H27N7O7 (453.1972)


   

Lys Cys Phe Gly

2-[(2S)-2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]-3-phenylpropanamido]acetic acid

C20H31N5O5S (453.2046)


   

Lys Cys Gly Phe

(2S)-2-{2-[(2R)-2-[(2S)-2,6-diaminohexanamido]-3-sulfanylpropanamido]acetamido}-3-phenylpropanoic acid

C20H31N5O5S (453.2046)


   

Lys Phe Cys Gly

2-[(2R)-2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]-3-sulfanylpropanamido]acetic acid

C20H31N5O5S (453.2046)


   

Lys Phe Gly Cys

(2R)-2-{2-[(2S)-2-[(2S)-2,6-diaminohexanamido]-3-phenylpropanamido]acetamido}-3-sulfanylpropanoic acid

C20H31N5O5S (453.2046)


   

Lys Gly Cys Phe

(2S)-2-[(2R)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-sulfanylpropanamido]-3-phenylpropanoic acid

C20H31N5O5S (453.2046)


   

Lys Gly Phe Cys

(2R)-2-[(2S)-2-{2-[(2S)-2,6-diaminohexanamido]acetamido}-3-phenylpropanamido]-3-sulfanylpropanoic acid

C20H31N5O5S (453.2046)


   

Asn His Pro Ser

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanoic acid

C18H27N7O7 (453.1972)


   

Asn His Ser Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O7 (453.1972)


   

Asn Pro His Ser

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H27N7O7 (453.1972)


   

Asn Pro Ser His

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O7 (453.1972)


   

Asn Ser His Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O7 (453.1972)


   

Asn Ser Pro His

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-carbamoylpropanamido]-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O7 (453.1972)


   

Pro His Asn Ser

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-hydroxypropanoic acid

C18H27N7O7 (453.1972)


   

Pro His Ser Asn

(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-3-(1H-imidazol-4-yl)-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]propanoic acid

C18H27N7O7 (453.1972)


   

Pro Asn His Ser

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]-3-hydroxypropanoic acid

C18H27N7O7 (453.1972)


   

Pro Asn Ser His

(2S)-2-[(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O7 (453.1972)


   

Pro Ser His Asn

(2S)-3-carbamoyl-2-[(2S)-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]-3-(1H-imidazol-4-yl)propanamido]propanoic acid

C18H27N7O7 (453.1972)


   

Pro Ser Asn His

(2S)-2-[(2S)-3-carbamoyl-2-[(2S)-3-hydroxy-2-[(2S)-pyrrolidin-2-ylformamido]propanamido]propanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O7 (453.1972)


   

Ser His Asn Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O7 (453.1972)


   

Ser His Pro Asn

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanoic acid

C18H27N7O7 (453.1972)


   

Ser Asn His Pro

(2S)-1-[(2S)-2-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoyl]pyrrolidine-2-carboxylic acid

C18H27N7O7 (453.1972)


   

Ser Asn Pro His

(2S)-2-{[(2S)-1-[(2S)-2-[(2S)-2-amino-3-hydroxypropanamido]-3-carbamoylpropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O7 (453.1972)


   

Ser Pro His Asn

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-(1H-imidazol-4-yl)propanamido]-3-carbamoylpropanoic acid

C18H27N7O7 (453.1972)


   

Ser Pro Asn His

(2S)-2-[(2S)-2-{[(2S)-1-[(2S)-2-amino-3-hydroxypropanoyl]pyrrolidin-2-yl]formamido}-3-carbamoylpropanamido]-3-(1H-imidazol-4-yl)propanoic acid

C18H27N7O7 (453.1972)


   

4-[3-(1-benzhydrylazetidin-3-yl)oxy-2-hydroxypropoxy]-1H-indole-2-carbonitrile

4-[3-(1-benzhydrylazetidin-3-yl)oxy-2-hydroxypropoxy]-1H-indole-2-carbonitrile

C28H27N3O3 (453.2052)


   

Deschlorodasatinib

Deschlorodasatinib

C22H27N7O2S (453.1947)


   

Netarsudil

Netarsudil

C28H27N3O3 (453.2052)


S - Sensory organs > S01 - Ophthalmologicals > S01E - Antiglaucoma preparations and miotics C78283 - Agent Affecting Organs of Special Senses > C29705 - Anti-glaucoma Agent

   

3-Azageranylgeranyl diphosphate

3-Azageranylgeranyl diphosphate

C19H37NO7P2 (453.2045)


   

Ethoheptazine citrate

Ethoheptazine citrate

C22H31NO9 (453.1999)


C78272 - Agent Affecting Nervous System > C67413 - Opioid Receptor Agonist

   
   

2-(3-(2-Aminoethyl)-1h-indol-5-yloxy)acetyl-l-tyrosyl-glycinamide

2-[(2-{[3-(2-aminoethyl)-1H-indol-5-yl]oxy}-1-hydroxyethylidene)amino]-N-[(C-hydroxycarbonimidoyl)methyl]-3-(4-hydroxyphenyl)propanimidate

C23H27N5O5 (453.2012)


   

3,5-Dimethyl-1-phenyl-4-pyrazolecarboxylic acid [2-[4-amino-1-methyl-3-(2-methylpropyl)-2,6-dioxo-5-pyrimidinyl]-2-oxoethyl] ester

3,5-Dimethyl-1-phenyl-4-pyrazolecarboxylic acid [2-[4-amino-1-methyl-3-(2-methylpropyl)-2,6-dioxo-5-pyrimidinyl]-2-oxoethyl] ester

C23H27N5O5 (453.2012)


   

(3R,3aS,7R,7aS)-3-[3-(4-acetylphenyl)-4-fluorophenyl]-7-methyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one

(3R,3aS,7R,7aS)-3-[3-(4-acetylphenyl)-4-fluorophenyl]-7-methyl-2-(phenylmethyl)-3a,6,7,7a-tetrahydro-3H-isoindol-1-one

C30H28FNO2 (453.2104)


   

(3R,3aR,7aR)-3-[4-(4-acetylphenyl)-2-fluorophenyl]-7a-methyl-2-(phenylmethyl)-3,3a,6,7-tetrahydroisoindol-1-one

(3R,3aR,7aR)-3-[4-(4-acetylphenyl)-2-fluorophenyl]-7a-methyl-2-(phenylmethyl)-3,3a,6,7-tetrahydroisoindol-1-one

C30H28FNO2 (453.2104)


   

3-butan-2-yl-1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-1-(2-phenylethyl)thiourea

3-butan-2-yl-1-[(6,7-dimethoxy-2-oxo-1H-quinolin-3-yl)methyl]-1-(2-phenylethyl)thiourea

C25H31N3O3S (453.2086)


   

N-[[(2R,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

N-[[(2R,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C25H28FN3O4 (453.2064)


   

1-[(1S)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1S)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C25H28FN3O4 (453.2064)


   

1-[(1R)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

1-[(1R)-2-[(2-fluorophenyl)methyl]-1-(hydroxymethyl)-7-methoxy-1-spiro[3,9-dihydro-1H-pyrido[3,4-b]indole-4,3-azetidine]yl]-2-methoxyethanone

C25H28FN3O4 (453.2064)


   

N-[[(2R,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

N-[[(2R,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C25H28FN3O4 (453.2064)


   

N-[[(2S,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

N-[[(2S,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C25H28FN3O4 (453.2064)


   

N-[[(2R,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

N-[[(2R,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C25H28FN3O4 (453.2064)


   

[(3aR,4S,9bS)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-pyridin-4-ylmethanone

[(3aR,4S,9bS)-4-(hydroxymethyl)-8-[2-(4-methoxyphenyl)ethynyl]-5-methyl-3,3a,4,9b-tetrahydro-2H-pyrrolo[3,2-c]quinolin-1-yl]-pyridin-4-ylmethanone

C28H27N3O3 (453.2052)


   

(6R,7R,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H28FN3O4 (453.2064)


   

(6R,7R,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H28FN3O4 (453.2064)


   

(6S,7S,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H28FN3O4 (453.2064)


   

(6S,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8R)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C28H27N3O3 (453.2052)


   

(6R,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C28H27N3O3 (453.2052)


   

N-[[(2S,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

N-[[(2S,3R)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C25H28FN3O4 (453.2064)


   

N-[[(2R,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

N-[[(2R,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C25H28FN3O4 (453.2064)


   

N-[[(2S,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

N-[[(2S,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2S)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C25H28FN3O4 (453.2064)


   

N-[[(2S,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

N-[[(2S,3S)-8-[2-(4-fluorophenyl)ethynyl]-5-[(2R)-1-hydroxypropan-2-yl]-3-methyl-6-oxo-3,4-dihydro-2H-pyrido[2,3-b][1,5]oxazocin-2-yl]methyl]-N-methylacetamide

C25H28FN3O4 (453.2064)


   

(6S,7S,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H28FN3O4 (453.2064)


   

(6R,7S,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7S,8S)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H28FN3O4 (453.2064)


   

(6S,7R,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-7-[4-(3-fluorophenyl)phenyl]-8-(hydroxymethyl)-4-[2-(4-morpholinyl)-1-oxoethyl]-1,4-diazabicyclo[4.2.0]octan-2-one

C25H28FN3O4 (453.2064)


   

(6S,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C28H27N3O3 (453.2052)


   

(6S,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6S,7S,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C28H27N3O3 (453.2052)


   

(6R,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8R)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C28H27N3O3 (453.2052)


   

(6R,7R,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

(6R,7R,8S)-8-(hydroxymethyl)-7-[4-[(E)-2-phenylethenyl]phenyl]-4-(2-pyridin-3-ylacetyl)-1,4-diazabicyclo[4.2.0]octan-2-one

C28H27N3O3 (453.2052)


   

2-amino-3-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

2-amino-3-[hydroxy-[2-hydroxy-3-[(Z)-tridec-9-enoyl]oxypropoxy]phosphoryl]oxypropanoic acid

C19H36NO9P (453.2128)


   

ST 20:3;O7;Gly

ST 20:3;O7;Gly

C22H31NO9 (453.1999)


   

Phe-Pro-Ala-pNA

Phe-Pro-Ala-pNA

C23H27N5O5 (453.2012)


Phe-Pro-Ala-pNA is a chromogenic substrate of tripeptidyl peptidase. Phe-Pro-Ala-pNA can be used to test tripeptidyl peptidase activity[1].

   

Temuterkib

Temuterkib

C22H27N7O2S (453.1947)


Temuterkib (LY3214996) is a highly selective inhibitor of ERK1 and ERK2, with IC50 of 5 nM for both enzymes in biochemical assays. Temuterkib potently inhibits cellular p-RSK1 in BRAF and RAS mutant cancer cell lines. Temuterkib shows potent antitumor activities in cancer models with MAPK pathway alterations.

   

(1r,3r)-5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile

(1r,3r)-5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile

C23H27N5O5 (453.2012)


   

(1r,3r,6s,13s,15s,16s,18s)-5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile

(1r,3r,6s,13s,15s,16s,18s)-5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile

C23H27N5O5 (453.2012)


   

5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile

5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile

C23H27N5O5 (453.2012)


   

2-amino-n-(4-carbamimidamido-1-{[hydroxy(1-hydroxy-2-methoxy-2-oxoethyl)phosphoryl](methyl)-c-hydroxycarbonohydrazonoyl}butyl)-3-methylbutanimidic acid

2-amino-n-(4-carbamimidamido-1-{[hydroxy(1-hydroxy-2-methoxy-2-oxoethyl)phosphoryl](methyl)-c-hydroxycarbonohydrazonoyl}butyl)-3-methylbutanimidic acid

C15H32N7O7P (453.2101)


   

(1r,3r,4r,6s,13s,15s,16s,18s)-5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile

(1r,3r,4r,6s,13s,15s,16s,18s)-5-(2-hydroxyethyl)-13-(hydroxymethyl)-10-methoxy-9,17-dimethyl-8,11-dioxo-5,14,17-triazapentacyclo[12.3.1.0³,¹⁶.0⁶,¹⁵.0⁷,¹²]octadeca-7(12),9-diene-4,18-dicarbonitrile

C23H27N5O5 (453.2012)